Shopping Cart 0
Cart Subtotal
AED 0

Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Astellas Pharma Inc (4503)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company's product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, diseases and disorders of central nervous system (CNS), and metabolic diseases, immunodeficiency diseases, and transplantation. It is investigating enfortumab vedotin in Phase 2 and Phase 3 clinical trials for the treatment of urothelial cancer; zolbetuximab in Phase 3 clinical trials for the treatment of gastric cancer and gastroesophageal junction cancer; roxadustat in Phase 3 clinical studies for the treatment of patients with anemia associated with chronic kidney disease (CKD) in patients on dialysis and non-dialysis; fezolinetant in Phase 2a clinical trials for the treatment of menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats; and gilteritinib for the treatment of for acute myeloid leukemia (AML). It operates in the Americas; Europe; and Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc Key Recent Developments

Apr 10,2019: Astellas and Concerto HealthAI to Launch Real-World Evidence Initiative on Acute Myeloid Leukemia Focused on Improving Patient Treatment and Outcomes

Apr 03,2019: Astellas announces key senior leadership promotions and new hire in Medical and Development organization

Mar 05,2019: ReForm Biologics announces collaboration agreement with Astellas Pharma

Jan 17,2019: Actinium successfully completes first module of collaborative research program with Astellas; second module initiated

Jan 10,2019: Astellas announces key Senior Leadership promotions and new hire in Medical and Development Organization

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Astellas Pharma Inc-Key Facts

Astellas Pharma Inc-Key Employees

Astellas Pharma Inc-Key Employee Biographies

Astellas Pharma Inc-Major Products and Services

Astellas Pharma Inc-History

Astellas Pharma Inc-Company Statement

Astellas Pharma Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Astellas Pharma Inc-Business Description

Product Category: OAB Products in Urology

Performance

Product Category: Other Products

Performance

Product Category: Prograf

Performance

Product Category: XTANDI

Performance

Geographical Segment: Asia and Oceana (Excluding Japan)

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: Japan

Performance

Geographical Segment: The Americas

Performance

R&D Overview

Astellas Pharma Inc-Corporate Strategy

Astellas Pharma Inc-SWOT Analysis

SWOT Analysis-Overview

Astellas Pharma Inc-Strengths

Astellas Pharma Inc-Weaknesses

Astellas Pharma Inc-Opportunities

Astellas Pharma Inc-Threats

Astellas Pharma Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Astellas Pharma Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 10, 2019: Astellas and Concerto HealthAI to Launch Real-World Evidence Initiative on Acute Myeloid Leukemia Focused on Improving Patient Treatment and Outcomes

Apr 03, 2019: Astellas announces key senior leadership promotions and new hire in Medical and Development organization

Mar 05, 2019: ReForm Biologics announces collaboration agreement with Astellas Pharma

Jan 17, 2019: Actinium successfully completes first module of collaborative research program with Astellas; second module initiated

Jan 10, 2019: Astellas announces key Senior Leadership promotions and new hire in Medical and Development Organization

Dec 17, 2018: Astellas buys Potenza Therapeutics for up to USD 405m

Dec 17, 2018: Astellas Pharmaceuticals named in advertisements for breach of ABPI Code of Practice

Dec 12, 2018: Astellas promotes Lei Ding to vice president, payer strategy, contracts, and pricing

Nov 20, 2018: Astellas Global Health Foundation launches-Foundation to support improving access to health for underserved populations

Nov 15, 2018: Astellas Announces Construction of R&D and Manufacturing Facilities in Japan and US

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Astellas Pharma Inc, Performance Chart (2015-2019)

Astellas Pharma Inc, Ratio Charts

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Astellas Pharma Inc, Key Facts

Astellas Pharma Inc, Key Employees

Astellas Pharma Inc, Key Employees (cont..)

Astellas Pharma Inc, Key Employee Biographies

Astellas Pharma Inc, Major Products and Services

Astellas Pharma Inc, History

Astellas Pharma Inc, Other Locations

Astellas Pharma Inc, Subsidiaries

Astellas Pharma Inc, Joint Venture

Astellas Pharma Inc, Key Competitors

Astellas Pharma Inc, Ratios based on current share price

Astellas Pharma Inc, Annual Ratios

Astellas Pharma Inc, Annual Ratios (Cont...1)

Astellas Pharma Inc, Annual Ratios (Cont...2)

Astellas Pharma Inc, Interim Ratios

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Astellas Pharma Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Astellas Pharma Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Kyowa Hakko Kirin Co Ltd

Otsuka Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Eisai Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Ceylon Tobacco Company PLC

Takeda Pharmaceutical Co Ltd

Stealth BioTherapeutics Corp

Astellas Pharma Inc (4503)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company's product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, diseases and disorders of central nervous system (CNS), and metabolic diseases, immunodeficiency diseases, and transplantation. It is investigating enfortumab vedotin in Phase 2 and Phase 3 clinical trials for the treatment of urothelial cancer; zolbetuximab in Phase 3 clinical trials for the treatment of gastric cancer and gastroesophageal junction cancer; roxadustat in Phase 3 clinical studies for the treatment of patients with anemia associated with chronic kidney disease (CKD) in patients on dialysis and non-dialysis; fezolinetant in Phase 2a clinical trials for the treatment of menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats; and gilteritinib for the treatment of for acute myeloid leukemia (AML). It operates in the Americas; Europe; and Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc Key Recent Developments

Apr 10,2019: Astellas and Concerto HealthAI to Launch Real-World Evidence Initiative on Acute Myeloid Leukemia Focused on Improving Patient Treatment and Outcomes

Apr 03,2019: Astellas announces key senior leadership promotions and new hire in Medical and Development organization

Mar 05,2019: ReForm Biologics announces collaboration agreement with Astellas Pharma

Jan 17,2019: Actinium successfully completes first module of collaborative research program with Astellas; second module initiated

Jan 10,2019: Astellas announces key Senior Leadership promotions and new hire in Medical and Development Organization

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Astellas Pharma Inc-Key Facts

Astellas Pharma Inc-Key Employees

Astellas Pharma Inc-Key Employee Biographies

Astellas Pharma Inc-Major Products and Services

Astellas Pharma Inc-History

Astellas Pharma Inc-Company Statement

Astellas Pharma Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Astellas Pharma Inc-Business Description

Product Category: OAB Products in Urology

Performance

Product Category: Other Products

Performance

Product Category: Prograf

Performance

Product Category: XTANDI

Performance

Geographical Segment: Asia and Oceana (Excluding Japan)

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: Japan

Performance

Geographical Segment: The Americas

Performance

R&D Overview

Astellas Pharma Inc-Corporate Strategy

Astellas Pharma Inc-SWOT Analysis

SWOT Analysis-Overview

Astellas Pharma Inc-Strengths

Astellas Pharma Inc-Weaknesses

Astellas Pharma Inc-Opportunities

Astellas Pharma Inc-Threats

Astellas Pharma Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Astellas Pharma Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 10, 2019: Astellas and Concerto HealthAI to Launch Real-World Evidence Initiative on Acute Myeloid Leukemia Focused on Improving Patient Treatment and Outcomes

Apr 03, 2019: Astellas announces key senior leadership promotions and new hire in Medical and Development organization

Mar 05, 2019: ReForm Biologics announces collaboration agreement with Astellas Pharma

Jan 17, 2019: Actinium successfully completes first module of collaborative research program with Astellas; second module initiated

Jan 10, 2019: Astellas announces key Senior Leadership promotions and new hire in Medical and Development Organization

Dec 17, 2018: Astellas buys Potenza Therapeutics for up to USD 405m

Dec 17, 2018: Astellas Pharmaceuticals named in advertisements for breach of ABPI Code of Practice

Dec 12, 2018: Astellas promotes Lei Ding to vice president, payer strategy, contracts, and pricing

Nov 20, 2018: Astellas Global Health Foundation launches-Foundation to support improving access to health for underserved populations

Nov 15, 2018: Astellas Announces Construction of R&D and Manufacturing Facilities in Japan and US

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Astellas Pharma Inc, Performance Chart (2015-2019)

Astellas Pharma Inc, Ratio Charts

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Astellas Pharma Inc, Key Facts

Astellas Pharma Inc, Key Employees

Astellas Pharma Inc, Key Employees (cont..)

Astellas Pharma Inc, Key Employee Biographies

Astellas Pharma Inc, Major Products and Services

Astellas Pharma Inc, History

Astellas Pharma Inc, Other Locations

Astellas Pharma Inc, Subsidiaries

Astellas Pharma Inc, Joint Venture

Astellas Pharma Inc, Key Competitors

Astellas Pharma Inc, Ratios based on current share price

Astellas Pharma Inc, Annual Ratios

Astellas Pharma Inc, Annual Ratios (Cont...1)

Astellas Pharma Inc, Annual Ratios (Cont...2)

Astellas Pharma Inc, Interim Ratios

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Astellas Pharma Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Astellas Pharma Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Kyowa Hakko Kirin Co Ltd

Otsuka Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Eisai Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Ceylon Tobacco Company PLC

Takeda Pharmaceutical Co Ltd

Stealth BioTherapeutics Corp